LONDON – A protein that can steer the estrogen receptor protein to different parts of the genome in cancer cells probably helps to determine the outcome of breast cancer, a new study has found.
To continue reading subscribe now to BioWorld Asia (formerly International)
Learn More about BioWorld Asia (formerly International)
Already a subscriber? Sign In or Buy now to activate your subscription
